Status:
WITHDRAWN
Cell Therapy in Limb Girdle Muscular Dystrophy
Lead Sponsor:
Neurogen Brain and Spine Institute
Conditions:
Limb Girdle Muscular Dystrophy
Eligibility:
All Genders
15-60 years
Phase:
PHASE1
Brief Summary
The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.
Eligibility Criteria
Inclusion
- age group of 15 years-60 years
- limb girdle muscular dystrophy diagnosed on the basis of clinical presentation
- Electromyographic and Nerve Conduction velocity findings
Exclusion
- presence of respiratory distress
- presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
- malignancies
- acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction \< 30%
- pregnancy or breastfeeding
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02245711
Start Date
December 1 2010
End Date
June 1 2015
Last Update
October 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurogen brain and spine institute
Navi Mumbai, Maharashtra, India, 400706